Glucagon-like peptide-1 receptor agonists such as liraglutide have revolutionized the management of type 2 diabetes and obesity.
Keywords: Glucagon-like peptide-1 receptor agonists, Hepatitis, Hepatotoxicity
Case reports in gastroenterology
Journal Article
English
41064547
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.